News, Money and Drugs for Tuesday, July 14, 2009

July 14, 2009 at 6:30 pm EST | Tags:

News, Money and Drugs for Tuesday, July 14, 2009

  • Today’s big news was Noven Pharmaceuticals. The transdermal drug maker was acquired by rival Japanese firm Hisamitsu Pharmaceutical for $430M. Noven was advised by elite law firm Cravath, Swaine & Moore. [DealBook]

  • Oscient Pharmaceuticals No. 1: Bankrupt! [Reuters]

  • Oscient Pharmaceuticals No. 2: No. 2 drug Sold! [Xconomy]

  • HPV data boosts Sequenom (SQNM) stock. [Reuters]

  • ReadClosely: Solvay/Abbott deal in the works? [The Deal]

  • Dear Shire, please tell us this is not true… [BNET Pharma]

  • Thumbs up for Wyeth – in Chile. [AP]

  • Thumbs down for Watson – in the U.S. [Pharmalive]

  • J&J talks Tylenol, Elan and some other stuff…zzzzzz. [Pharmalive]

  • Last, but not least, the most interesting story of the day that didn’t get mindlessly copied and pasted everywhere was Wynonna Judd. Yeah, Wynnona Judd. Judd put on a private concert on Saturday at the Country Music Hall of Fame in Nashville in honor of GSK’s weight loss drug alli. Judd is alli’s spokesperson and has lost 2 dress sizes since starting. The concert was exclusively for 50 sweepstakes winners, most of which have also lost weight on the drug. Where’s Biggie Smalls when you need him??? [PR Newswire]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts

| News, Money and Drugs for Tuesday, July 7, 2009 | News, Money and Drugs for Tuesday, June 9, 2009 | News, Money and Drugs for Tuesday, June 30, 2009 | News, Money and Drugs for Thursday, July 9, 2009 | News, Money and Drugs for Friday, July 17, 2009 |


Leave a Reply

Would you like to register?